Wernicke's encephalopathy: An excitotoxicity hypothesis

Metabolic Brain Disease

Volumn 12, Issue 3, 1997, Pages 183-192

  McEntee, William J ^a  

^a Clinical Studies Ltd   (United States)

Author keywords

Circumventricular organs; Excitotoxicity; Glutamate; Neurotoxicity; Thiamine deficiency; Wernicke Encephalopathy

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID;

BRAIN AQUEDUCT; BRAIN REGION; HUMAN; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

ANIMALS; BRAIN; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MODELS, NEUROLOGICAL; NEUROTOXINS; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

SYLVIA;

EID: 0030850991     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000007099.18010.72     Document Type: Review

References (47)

1. Aikawa, H., Watanabe, I.S., Furuse, T., Iwasaki, Y., Satoyoshi, E., Sumi, T. and Moroji, T. (1984). Low energy levels in thiamine-deficient encephalopathy. J. Neuropath. Exp. Neurol. 43:276-287.
2. Armstrong-James, M., Ross, D.T., Chen, F. and Ebner, F.F. (1988). The effect of thiamine deficiency on the structure and physiology of the rat forebrain. Metab. Brain Dis. 3:91-124.
3. Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N.H. (1984). Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1369-1374.
4. Bouldin, T.W. and Krigman, M.R. (1975). Differential permeability of cerebral capillary and choroid plexus to lanthanum ion. Brain Res. 99:444-448.
5. Brightman, M.W. (1965). The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution. Am. J. Anal. 117:193-220.
6. Brightman, M.W. (1975). Ultrastructural characteristics of adult choroid plexus: Relation to the blood-cerebrospinal fluid barrier to proteins. In (M.G. Netsky and S. Shuangshoti, eds.) The Choroid Plexus in Health and Disease, University Press of Virginia, Charlottesville, pp. 86-112.
7. Brightman, M.W. and Reese, T.S. (1969). Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40:648-677.
8. Butterworth, R.F. (1982). Neurotransmitter function in thiamine-deficiency encephalopathy. Neurochem. Int. 4:449-464.
9. Butterworth, R.F. (1986). Cerebral thiamine-dependent enzyme changes in experimnetal Wernicke's encephalopathy. Metab. Brain Dis. 1:165-175.
10. Butterworth, R.F. (1989). Effects of thiamine deficiency on brain metabolism: Implications for the pathogenesis of the Wernicke-Korsakoff syndrome. Alcohol Alcoholism. 24:271-279.
11. Butterworth, R.F., Hamel, E., Landreville, F. and Barbeau, A. (1979). Amino acid changes in thiamine-deficient encephalopathy: Some implications for the pathogenesis of Friedreich's ataxia. Can. J. Neurol. Sci. 6:217-222.
12. Butterworth, R.F., Giguere, J.F. and Besnard, A.M. (1986). Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. Ketoglutarate dehydrogenase. Neurochem. Res. 11:567-577.
13. Castel, M., Sahar, A. and Erlij, D. (1974). The movement of lanthanum across diffusion barriers in the choroid plexus of the cat. Brain Res. 67:178-184.
14. Erdo, S.L. (1992). Non-neuronal GABA systems: An overview. In (S.L. Erdo, ed.) GABA Outside the CNS, Springer-Verlag, Berlin, pp. 97-110.
15. Gaitonde, M.K., Fayein, N.A. and Johnson, A.L. (1975). Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine. J. Neurochem. 24:1215-1223.
16. Gibson, G.E., Ksiezak-Reding, H., Sheu, K.F.R., Mykytyn, V. and Blass, J.P. (1984). Correlation of enzymatic, metabolic, and behavioral deficits in thiamine deficiency and its reversal. Neurochem. Res. 9:803-814.
17. Gomez, D.G. and Potts, D.G. (1981). The lateral, third and fourth ventricle choroid plexus of the dog: A structural and ultrastructural study. Ann. Neurol. 10:333-340.
18. Gross, P.M. (1991). Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrema. Can. J. Physiol. Pharmacol. 69:1010-1025.
19. Gross, P.M. and Weindl, A. (1987). Peering through the windows of the brain. J. Cereb. Blood Flow Metab. 7:663-672.
20. Gross, P.M., Wall, K.M., Pang, J.J., Shaver, S.W. and Wainman, D.S. (1990). Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol. 259:R1131-R1138.
21. Gubler, C.J., Adams, B.L., Hammond, B., Chuan-Yuan, E., Guo, S.T.I. and Bennion M. (1974). Effect of thiamin deprivation and thiamin antagonists on the level of aminobutyric acid and on 2-oxo-glutarate metabolism in rat brain. J. Neurochem. 22:831-836.
22. Gullotta, F. (1968). Lokalisation der Wernicke-encephalopathie im kindes- und erwachsenenalter. Arch. Psychiat. Nervenkr. 211:88-108.
23. Harata, N. and Iwasaki, Y. (1996). The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse. Metab. Brain Dis. 11:55-69.
24. Hazell, A.S., Butterworth, R.F. and Hakim, A.M. (1993). Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J. Neurochem. 61:1155-1158.
25. Holowach, J., Kaufmann, F., Ikossi, M.G., Thomas, C. and McDougal, D.B. (1968). The effects of a thiamine antagonist, pyrithiamine, on levels of selected metabolic intermediates and activities of thiamine dependent enzymes in brain and liver. J. Neurochem. 15:621-631.
26. Kvamme, E., Schousboe, A., Hertz, L., Torgner, I.A. and Svenneby, G. (1985). Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo. Neurochem. Res. 10:993-1008.
27. Lajtha, A., Berl, S. and Waelsch, H. (1959). Amino acid and protein metabolism of the brain. J. Neurochem. 3:322-332.
28. Langlais, P.J. and Mair, R.G. (1990). Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J. Neurosci. 10:1664-1674.
29. Langlais, P.J. and Zhang, S.X. (1993). Extracellular glutamate is increased in thalamus during thiamine deficiency and is blocked by MK-801. J. Neurochem. 61:2175-2182.
30. Langlais, P.J., Mair, R.G., Anderson, C.D. and McEntee, W.J. (1988). Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats. Neurochem. Res. 13:1199-1206.
31. Mair, R.G., Anderson, C.D., Langlais, P.J. and McEntee, W.J. (1988). Behavioral impairments, brain lesions and monoaminergic activity in the rat following recovery from a bout of thiamine deficiency. Behav. Brain. Res. 27:223-239.
32. Mancall, E.L. and McEntee, W.J. (1965). Alterations of the cerebellar cortex in nutritional encephalopathy. Neurology. 15:303-313.
33. McCandless, D.W. (1982). Energy metabolism in the lateral vestibular nucleus in pyrithiamine-induced thiamine deficiency. Ann. N.Y. Acad. Sci. 378:355-364.
34. McCandless, D.W. and Schenker, S. (1968). Encephalopathy of thiamine deficiency: Studies of intracerebral mechanisms. J. Clin. Invest. 47:2268-2280.
35. McCandless, D.W. and Schwartzenburg, F.C. (1981). The effect of thiamine deficiency on energy metabolism in cells of the lateral vestibular nucleus. Res. Comm. Psychol. Psychiat. Behav. 6:183-190
36. Novelli, A., Reilly, J.A., Lysko, P.G. and Henneberry, R.C. (1988). Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:205-212.
37. Page, M.G., Ankoma-Sey, V., Coulson, W.F. and Bender, D.A. (1989). Brain glutamate and gamma-aminobutyrate (GABA) metabolism in thiamine-deficient rats. Brit. J. Nutr. 62:245-253.
38. Price, M.T., Olney, J.W., Lowry, O.H. and Bachsbaum, S. (1981). Uptake of exogenous glutamate and aspartate by circumventricular organs but not other regions of the brain. J. Neurochem. 36:1774-1780.
39. Riggs, H.E. and Boles, R.S. (1944). Wernicke's disease: A clinical and pathologic study of 42 cases. Quart. J. Stud. Alcohol. 5:361-370.
40. Robinson, J,K. and Mair, R.G. (1992). MK-801 protects rats from brain lesions and behavioral impairment following pyrithiamine-induced thiamine deficiency (PTD). Behav. Neurosci. 106:623-633.
41. Toth, E. and Lajtha, A. (1981). Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses. Neurochem. Res. 6:1309-1317.
42. Troncoso, J.C., Johnston, M.V., Hess, K.M. Griffin, J.W. and Price, D.L. (1981). Model of Wernicke's encephalopathy. Arch. Neurol. 38:350-354.
43. Victor, M. and Yakovlev, P.I. (1955). S.S. Korsakoffs psychic disorder in conjunction with peripheral neuritis, Neurology. 5:394-406.
44. Victor, M., Adams, R.D. and Collins, G,H. (1989). The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders due to Alcoholism and Malnutrition. 2nd ed., F.A. Davis, Philadelphia.
45. Watanabe, I.S. and Kanabe S. (1978). Early edematous lesion of pyrithiamine-induced acute thiamine deficient encephalopathy in the mouse. J. Neuropathol. Exp. Neurol. 37:401-413.
46. Weindl, A. and Joynt, R.J. (1973). Barrier properties of the subcommisural organ. Arch. Neurol. 29:16-22.
47. Zeevalk, G.D. and Nicklas, W.J. (1990). Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253:1285-1292.